Expression of matrix metalloproteinases and their inhibitors in human brain tumors

Ann N Y Acad Sci. 1999;886:236-9. doi: 10.1111/j.1749-6632.1999.tb09425.x.

Abstract

Sixty human brain tumors, including grade I meningiomas, schwannomas, and pilocytic astrocytomas, grade II astrocytomas, grade III anaplastic astrocytomas and oligodendrogliomas, and grade IV glioblastomas and lung and melanoma metastases were analyzed for expression of four matrix metalloproteinases (MMPs), two tissue inhibitors of MMPs (TIMPs), and MMP activity. No marked correlation was found between MMP expression and the degree of malignancy. Western blotting analysis revealed a more uniform pattern of distribution of MMP-2 (gelatinase A) than of MMP-9 (gelatinase B) and MMP-12 (metalloelastase) among tumors. All 60 tumors showed a similar pattern of activity in zymography, MMP-2 being the major species detected. Interestingly, TIMP-1 and TIMP-2 expression levels were low in tumors of grade III but significantly higher in tumors of grade I, particularly schwannomas. Altogether, these data suggest that: (1) the balance between MMP-2 and TIMP-2 is important in human brain tumors; and (2) TIMP expression may be a valuable marker for tumor malignancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Brain Neoplasms / enzymology*
  • Brain Neoplasms / metabolism
  • Fluorometry
  • Humans
  • Matrix Metalloproteinases / metabolism*
  • Tissue Inhibitor of Metalloproteinases / metabolism*

Substances

  • Tissue Inhibitor of Metalloproteinases
  • Matrix Metalloproteinases